Daewoong Pharmaceutical Co., Ltd (KRX:069620)
100,100
-600 (-0.60%)
Nov 17, 2026, 3:30 PM KST
Daewoong Pharmaceutical Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Daewoong Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ₩188,000. The average 1-year stock price forecast is 87.81% higher than the current stock price, while the lowest is ₩150,000 (+49.85%) and the highest is ₩220,000 (+119.78%).
Price Target: ₩188,000 (+87.81%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Daewoong Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Buy | 6 | 5 | 6 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 9 | 10 | 10 | 10 | 10 |
Financial Forecast
Revenue This Year
1.48T
from 1.57T
Decreased by -5.62%
Revenue Next Year
1.50T
from 1.48T
Increased by 1.47%
EPS This Year
14.18K
from 14.45K
Decreased by -1.86%
EPS Next Year
8.77K
from 14.18K
Decreased by -38.14%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.